Black Diamond Therapeutics Inc
BDTX
$1.70-4.24%
Delayed · as of Oct 13, 2026, 11:15 AM ET
Mkt cap
$95.69M
EV/Sales
1.07
P/E ratio
N/A
FY2025 Revenue
$70.00M
EPS (H1 2026)
$-0.33
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
31.95%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
Latest reported BDTX revenue for 2025-12-31 was $70.0M. Net income was $22.4M. BDTX currently screens at market cap $95.7M.
Use this BDTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BDTX income, balance, and cash tables.
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company in the Healthcare sector.
Latest cached Black Diamond Therapeutics Inc (BDTX) revenue for Dec 31, 2025 was $70.0M. Net income was $22.4M. Statements: https://lician.com/financials/bdtx
Black Diamond Therapeutics Inc (BDTX) market capitalization is $95.7M on the latest cached snapshot.
Black Diamond Therapeutics Inc (BDTX) cached previous close $1.77; day range $1.70 – $1.76; volume 170,112. Session quote: https://lician.com/quote/bdtx
Black Diamond Therapeutics Inc (BDTX) latest cached earnings event is "BDTX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BDTX filing is 8-K · Jun 29, 2026. Filings: https://lician.com/sec/bdtx